John Ryals, PhD, President and CEO of Metabolon, explains how metabolites can be a powerful precision medicine ally, for both researchers and clinicians
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Creating smart ‘intelligent’ drugs could become a reality following the development of a DNA computer capable of detecting antibodies in the blood
Patients facing grim outlook from treatment-resistant disease now thriving thanks to new genomic testing of biopsy samples
21-gene expression assay could reveal which women will benefit most from chemotherapy in the early stages of breast cancer
Gene therapy shows significant progress for restoring muscle strength and prolonging lives in dogs with an incurable, inherited neuromuscular disease
Why do some people get Type 2 diabetes, while others who live the same lifestyle never do?
New study has discovered mutations within a gene not previously linked to congenital muscular dystrophy that could lead to faster diagnoses
Genetic predictors of normal prostate-specific antigen levels in healthy men could improve the accuracy of PSA-based prostate cancer screening tests
Studies in mice have found that blocking a newly identified genetic marker can reduce the neural activation caused by painful stimuli like serious burns
Study of over ten million DNA variations has found links between the human genome and inflammation tracers, and options for treating inflammatory disease
A new study by The Scripps Research Institute gives a first look at the early stages of brain development in patients with Fragile X syndrome